Citation Impact
Citing Papers
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
1990
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
1989
The relationship between prognostic and predictive factors in the management of breast cancer
1998
HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer
2004
Prognostic Factors in Breast Cancer
2000
EGFR Antagonists in Cancer Treatment
2008 Standout
Epidermal growth factor receptor expression as a prognostic indicator in breast cancer
1991
Adult rat and human bone marrow stromal cells differentiate into neurons
2000 Standout
Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin
2004 StandoutNobel
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibody
1990
Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases
2000
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
1991
Tumor-Associated Macrophages in Breast Cancer
2002
Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines
1998
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1995
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Growth factors and oncogenes in breast cancer
1990
The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancer
1993
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin
2000
The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*
1992
Cancer Metastasis: Building a Framework
2006 Standout
Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas
1991
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors
1992
Renal-Cell Carcinoma
1996 Standout
Signaling Pathways Leading to Transcription and Translation Cooperatively Regulate the Transient Increase in Expression of c-Fos Protein
2001 StandoutNobel
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
2003
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
2004
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
2005
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri
1996
Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants
2005 StandoutNatureNobel
Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma
1995
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status
1989
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer
1988
Immunohistochemical localization of c-erbB-2 in human breast carcinomas
1987
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
2001
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival
1994
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
2001
Transcriptional regulation of ABC drug transporters
2003
Neuroblastoma
2007 Standout
Quantitative reactivity profiling predicts functional cysteines in proteomes
2010 StandoutNatureNobel
The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
1994
The epidermal growth factor receptor as a target for therapy in breast carcinoma
1994
Prognostic significance of transforming growth factor-α in human esophageal carcinoma implication for the autocrine proliferation
1993
Hydrogels based on chitosan and dextran as potential drug delivery systems
1999
Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and theor relation to estradiol receptor (ER) status
1997
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
EGF receptor expression in primary laryngeal cancer: Correlation with clinico‐pathological features and prognostic significance
1992
The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
1994 Standout
Antitumor activity of the selective epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) Iressa® (ZD1839) in an EGFR‐expressing multidrug‐resistant cell line in vitro and in vivo
2001
Modifications of the hydrophilicity of heterocyclic methacrylate copolymers for protein release
1995
A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer.
1993
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Telomerase Activity in Human Breast Tumors
1996
Advances in Malignant Mesothelioma
2005 Standout
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
2006 Standout
Head and Neck Cancer
2001 Standout
The Association of Epstein-Barr Virus (Ebv) with T Cell Lymphoproliferations and hodgkin's Disease: Two New Developments in the Ebv Field
1993
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Epstein–Barr Virus Infection
2000 Standout
Osteoblasts in prostate cancer metastasis to bone
2005
Cancer of the Ovary
2004 Standout
Cytogenetic analysis of primitive neuroectodermal tumors
1991
Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy
2009
Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion.
1991
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
2000
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor, c‐erbB‐2 protein, estrogen receptor related protein, p21‐ras protein, and proliferation indicators in relation to tumor recurrences and patient survival
1995
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Polymeric Systems for Controlled Drug Release
1999 Standout
Integrins: Versatility, modulation, and signaling in cell adhesion
1992 Standout
Luminescent Chemodosimeters for Bioimaging
2012 Standout
The epidermal growth factor receptor and the prognosis of bladder cancer
1990
Telomerase activity, cell proliferation, and cancer
1998 StandoutNobel
Epidermal growth factor receptors in non-small cell lung cancer
1987
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
High-dose rapid schedule chemotherapy for disseminated neuroblastoma
1992
Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
1993
Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy
1994
Type 1 growth factor receptors: an overview of recent developments
1995
Glutathione S-transferase expression in benign and malignant ovarian tumours
1993
Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression
2004
Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product.
1994
Design and Synthesis of Highly Sensitive Fluorogenic Substrates for Glutathione S-Transferase and Application for Activity Imaging in Living Cells
2008
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group Study
2000
Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
1995
Epidermal growth factor receptor in human breast cancer: Correlation with steroid hormone receptors and axillary lymph node involvement
1988
Molecular Biology of Neuroblastoma
1999
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer.
1988
Diagnosis of multiple cancer types by shrunken centroids of gene expression
2002 Standout
Integrated Analysis of Exosomal Protein Biomarkers on Alternating Current Electrokinetic Chips Enables Rapid Detection of Pancreatic Cancer in Patient Blood
2018
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 StandoutScience
Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone
2002 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Works of A J Malcolm being referenced
Apoptosis of N-Type Neuroblastoma Cells After Differentiation With 9-cis-Retinoic Acid and Subsequent Washout
1997
Gene expression and neuroblastoma cell Differentiation in response to retinoic acid: Differential effects of 9-cis and all-trans retinoic acid
1995
Demonstration of Epstein‐Barr viral DNA in formalin‐fixed, paraffin‐embedded samples of Hodgkin's disease
1990
Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies
1998
Solid alveolar rhabdomyosarcoma with a t(2;13)
1995
Cytogenetic abnormalities of small round cell tumours
1994
Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.
1985
Growth Hormone in Polymethylmethacrylate Cement
1990
Routine histological compared with immunohistological examination of bone marrow trephine biopsy specimens in disseminated neuroblastoma.
1991
Improved method for immunoperoxidase detection of membrane antigens in frozen sections.
1989
Glutathione S-transferase in bone marrow metastases of disseminated neuroblastoma.
1994
Investigation of coamplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a dead box gene, DDX1, in neuroblastoma
1996
Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
1996
Cytogenetic investigations of solid tumours of children.
1988
Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia.
1994
Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens.
1992
EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER
1987
Cytogenetic abnormalities in a primitive neuroectodermal tumor
1988